Ruskhim, the owner of the OOO Donbiotech plant in the Rostov Oblast, which recently said that its lysine sulphate factory would be opened by 2026, intends to invest another 85 billion roubles (approximately $900 million) to launch production of feed tryptophan, valine and threonine at the site, Marina Bortova, deputy general director of the plant, disclosed.
No timeline was provided and Ruskhim has not disclosed any additional details about the tryptophan, valine and threonine project.
Of note, since Ruskhim announced the 2026 opening for its lysine sulphate production, local analysts have expressed doubts about whether establishing new capacities for lysine in Russia is justified as domestic demand for lysine is already largely met.
In another project, Salavat Chemical Plant, a Bashkortostan-based chemical company, plans to launch production of choline chloride (vitamin B4) by 2026, the company recently unveiled. The planned capacity is 23,500 tonnes/year of 60% choline chloride on a solid carrier and 25,000 tonnes/year of liquid choline chloride (70-75%).
The company will establish choline chloride production as soon as possible, said Maria Kozlova, head of the long-term development department of Salavat Chemical Plant.
Salavat Chemical Plant estimates that choline chloride accounts for 54% of Russian feed vitamin imports.
One of the reasons why choline chloride has always been imported to Russia is because the country lacks production of one of its key components – trimethylamine, explained Kozlova.
Commenting on Russia’s self-sufficiency for feed additives, Sergey Mikhnyuk, executive director of the National Feed Union, said: "We are sure that the quantity [of the new projects in the industry] will soon transform into qualitative [projects], and new production sites will also be put into operation.”
